India COVID-19 Vaccines Market Report 2021-2027: Products, Services, and Continuous Product Developments – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “India COVID-19 Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2027)” report has been added to ResearchAndMarkets.com’s offering.

India’s COVID-19 vaccines market is anticipated to grow over US$ 2.3 Billion by 2027 with an impressive CAGR of more than 25% during the forecast period.

The report offers the most up-to-date industry data on the actual market situation and future outlook for the India COVID-19 vaccines market. The study also presents a comprehensive analysis of the market dynamics and estimation of the market size over the forecast period 2021 – 2027.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends, the number of persons being vaccinated, and doses administered of the COVID-19 vaccines in the Indian Market. The report also explores a detailed analysis of the introduction of the COVID-19, prevention, and vaccines for COVID-19 in the Indian Market.

The report also delivers a detailed assessment of the latest happenings in the Indian COVID-19 vaccines market. It also discovers a comprehensive investigation of the development and key marketed COVID-19 vaccines in India.

The report also offers detailed information about the roles of different Indian ministries/departments in COVID-19 vaccine implementation and the COVID-19 vaccine intelligence network (Co-WIN).

The report also tracks and analyses competitive developments, including collaboration, partnerships, exclusive and licensing agreements, new vaccine developments, and R&D activities in the market. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.

The report concludes with the profiles of the key players in the Indian COVID-19 vaccines market. The key players are evaluated on various parameters such as business overview, COVID-19 vaccines portfolio, promising vaccines in the clinical development, and recent development.

The prominent factors that are expected to contribute to the growth of the Indian COVID-19 vaccines market during the forecast period:

• Approval/launches of the New Vaccines
• Rising focus on immunization programs
• Increasing government support for the vaccine development

The Major Companies Dominating this Market for their Products, Services, and Continuous Product Developments are:

• Bharat Biotech International Limited
• Serum Institute of India
• Zydus Cadila
• Biological E. Limited
• Gennova Biopharmaceuticals Limited
• Dr. Reddy’s Laboratories Ltd.

Key Topics Covered:

1. Executive Summary

2. Introduction: COVID-19, Prevention and Vaccines

2.1 About COVID-19

2.2 Prevention of COVID-19

2.3 Vaccines for COVID-19

3. India COVID-19 Vaccines Market Size and Analysis (2021 – 2027)

4. India Number of Persons Vaccinated with COVID-19 Vaccines (2021 – 2027)

5. India Number of Doses Administered with COVID-19 Vaccines (2021 – 2027)

6. Key Market Drivers and Inhibitors of the India COVID-19 Vaccines Market

6.1 Market Drivers

6.2 Market Inhibitors

7. Latest Happenings in the India COVID-19 Vaccines Market

8. COVID-19 Vaccines Development in India

9. Key Marketed Vaccines for COVID-19 in India

10. Roles of Different Indian Ministries/Departments in COVID-19 Vaccines Implementation

11. COVID-19 Vaccine Intelligence Network (Co-WIN): The Digital Platform

12. Major Deals and Agreement Happenings in the India COVID-19 Vaccines Market

12.1 Collaboration Deals

12.2 Partnership Deals

12.3 Licensing Agreement

13. Key Players Analysis

13.1 Bharat Biotech International Limited

13.1.1 Business Overview

13.1.2 COVID-19 Vaccine Portfolio

13.1.3 Promising COVID-19 Vaccine in the Clinical Development

13.1.4 Recent Development

13.2 Serum Institute of India

14. Emerging Players Analysis

14.1 Zydus Cadila

14.1.1 Business Overview

14.1.2 Promising COVID-19 Vaccine in the Clinical Development

14.1.3 Recent Development

14.2 Biological E. Limited

14.3 Gennova Biopharmaceuticals Limited

14.4 Dr. Reddy’s Laboratories Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/c944i6

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900